U.S. C-Reactive Protein Testing Market Demand, Growth Opportunity, 2025-2034

Table of Contents

    1. Introduction
        1.1. Report Description
            1.1.1.  Objectives of the Study
            1.1.2.  Market Scope
            1.1.3.  Assumptions
        1.2. Stakeholders
    2. Executive Summary
        2.1. Market Highlights
    3. Research Methodology
        3.1. Overview
            3.1.1.  Data Mining
        3.2. Data Source
            3.2.1.  Primary Source
            3.2.2.  Secondary Source
    4. U.S. C-Reactive Protein Testing Market Insights
        4.1. C-Reactive Protein Testing Market – Market Snapshot
        4.2. C-Reactive Protein Testing Market Dynamics
            4.2.1.  Drivers and Opportunities
                4.2.1.1. Increasing Demand for Precision Medicine
                4.2.1.2. Increasing Burden of Chronic Diseases such as Cardiovascular Disorders
            4.2.2.  Restraints and Challenges
                4.2.2.1. Lack of Specificity
        4.3. Porter’s Five Forces Analysis
            4.3.1.  Bargaining Power of Suppliers (Moderate)
            4.3.2.  Threats of New Entrants: (Low)
            4.3.3.  Bargaining Power of Buyers (Moderate)
            4.3.4.  Threat of Substitute (Moderate)
            4.3.5.  Rivalry among existing firms (High)
        4.4. PESTEL Analysis
        4.5. C-Reactive Protein Testing Market Trends
        4.6. Value Chain Analysis
    5. U.S. C-Reactive Protein Testing Market, by Assay Type
        5.1. Key Findings
        5.2. Introduction
            5.2.1. U.S. C-Reactive Protein Testing Market, by Assay Type, 2020-2034 (USD Million)
        5.3. Immuno-turbidimetric Assay
            5.3.1. U.S. C-Reactive Protein Testing Market, by Immuno-turbidimetric Assay, by Region, 2020-2034 (USD Million)
        5.4. ELISA
            5.4.1. U.S. C-Reactive Protein Testing Market, by ELISA, by Region, 2020-2034 (USD Million)
        5.5. Clinical
            5.5.1.  U.S. C-Reactive Protein Testing Market, by Clinical, by Region, 2020-2034 (USD Million)
        5.6. Non-clinical
            5.6.1.  U.S. C-Reactive Protein Testing Market, by Non-clinical, by Region, 2020-2034 (USD Million)
        5.7. Chemiluminescence Immunoassay
            5.7.1.  U.S. C-Reactive Protein Testing Market, by Chemiluminescence Immunoassay, by Region, 2020-2034 (USD Million)
        5.8. Others
            5.8.1.  U.S. C-Reactive Protein Testing Market, by Others, by Region, 2020-2034 (USD Million)
    6. U.S. C-Reactive Protein Testing Market, by Detection Range
        6.1. Key Findings
        6.2. Introduction
            6.2.1. U.S. C-Reactive Protein Testing Market, by Detection Range, 2020-2034 (USD Million)
        6.3. hs (high sensitivity) CRP
            6.3.1. U.S. C-Reactive Protein Testing Market, by hs (high sensitivity) CRP, by Region, 2020-2034 (USD Million)
        6.4. Conventional CRP
            6.4.1. U.S. C-Reactive Protein Testing Market, by Conventional CRP, by Region, 2020-2034 (USD Million)
        6.5. cCRP
            6.5.1. U.S. C-Reactive Protein Testing Market, by cCRP, by Region, 2020-2034 (USD Million)
    7. U.S. C-Reactive Protein Testing Market, by Disease Area
        7.1. Key Findings
        7.2. Introduction
            7.2.1. U.S. C-Reactive Protein Testing Market, by Disease Area, 2020-2034 (USD Million)
        7.3. Cardiovascular Diseases
            7.3.1. U.S. C-Reactive Protein Testing Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Million)
        7.4. Cancer
            7.4.1. U.S. C-Reactive Protein Testing Market, by Cancer, by Region, 2020-2034 (USD Million)
        7.5. Rheumatoid Arthritis
            7.5.1. U.S. C-Reactive Protein Testing Market, by Rheumatoid Arthritis, by Region, 2020-2034 (USD Million)
        7.6. Inflammatory Bowel Disease
            7.6.1. U.S. C-Reactive Protein Testing Market, by Inflammatory Bowel Disease, by Region, 2020-2034 (USD Million)
        7.7. Endometriosis
            7.7.1. U.S. C-Reactive Protein Testing Market, by Endometriosis, by Region, 2020-2034 (USD Million)
        7.8. Lupus
            7.8.1. U.S. C-Reactive Protein Testing Market, by Lupus, by Region, 2020-2034 (USD Million)
        7.9. Others
            7.9.1. U.S. C-Reactive Protein Testing Market, by Others, by Region, 2020-2034 (USD Million)
    8. U.S. C-Reactive Protein Testing Market, by End Use
        8.1.  Key Findings
        8.2.  Introduction
            8.2.1. U.S. C-Reactive Protein Testing Market, by End Use, 2020-2034 (USD Million)
        8.3. Clinics
            8.3.1. U.S. C-Reactive Protein Testing Market, by Clinics, by Region, 2020-2034 (USD Million)
        8.4. Hospitals
            8.4.1. U.S. C-Reactive Protein Testing Market, by Hospitals, by Region, 2020-2034 (USD Million)
        8.5. Laboratories
            8.5.1. U.S. C-Reactive Protein Testing Market, by Laboratories, by Region, 2020-2034 (USD Million)
        8.6. Assisted Living Healthcare Facilities
            8.6.1. U.S. C-Reactive Protein Testing Market, by Assisted Living Healthcare Facilities, by Region, 2020-2034 (USD Million)
        8.7. Home Care Settings
            8.7.1. U.S. C-Reactive Protein Testing Market, by Home Care Settings, by Region, 2020-2034 (USD Million)
        8.8. Others
            8.8.1. U.S. C-Reactive Protein Testing Market, by Others, by Region, 2020-2034 (USD Million)
    9. Competitive Landscape
        9.1. Expansion and Acquisition Analysis
            9.1.1. Expansion
            9.1.2. Acquisitions
        9.2. Partnerships/Collaborations/Agreements/Exhibitions
    10. Company Profiles
        10.1. Abbott Laboratories
            10.1.1. Company Overview
            10.1.2. Financial Performance
            10.1.3. Product Benchmarking
            10.1.4. Recent Development
        10.2. Boditech Med
            10.2.1. Company Overview
            10.2.2. Financial Performance
            10.2.3. Product Benchmarking
            10.2.4. Recent Development
        10.3. F. Hoffmann-La Roche Ltd
            10.3.1. Company Overview
            10.3.2. Financial Performance
            10.3.3. Product Benchmarking
            10.3.4. Recent Development
        10.4. Getein Biotech
            10.4.1. Company Overview
            10.4.2. Financial Performance
            10.4.3. Product Benchmarking
            10.4.4. Recent Development
        10.5. HORIBA Ltd 
            10.5.1. Company Overview
            10.5.2. Financial Performance
            10.5.3. Product Benchmarking
            10.5.4. Recent Development
        10.6. Merck KGaA
            10.6.1. Company Overview
            10.6.2. Financial Performance
            10.6.3. Product Benchmarking
            10.6.4. Recent Development
        10.7. Quest Diagnostics Incorporated 
            10.7.1. Company Overview
            10.7.2. Financial Performance
            10.7.3. Product Benchmarking
            10.7.4. Recent Development
        10.8. Randox Laboratories
            10.8.1. Company Overview
            10.8.2. Financial Performance
            10.8.3. Product Benchmarking
            10.8.4. Recent Development
        10.9. Siemens Healthineers 
            10.9.1. Company Overview
            10.9.2. Financial Performance
            10.9.3. Product Benchmarking
            10.9.4. Recent Development
        10.10. Thermo Fisher Scientific, Inc.
            10.10.1. Company Overview
            10.10.2. Financial Performance
            10.10.3. Product Benchmarking
            10.10.4. Recent Development

    List of Tables:

    Table 1 U.S. C-Reactive Protein Testing Market, by Assay Type, 2020-2034 (USD Million)
    Table 2 U.S. C-Reactive Protein Testing Market, by Detection Range, 2020-2034 (USD Million)
    Table 3 U.S. C-Reactive Protein Testing Market, by Disease Area, 2020-2034 (USD Million)
    Table 4 U.S. C-Reactive Protein Testing Market, by End Use, 2020-2034 (USD Million)

    List of Figures:

    Figure 1. U.S. C-Reactive Protein Testing Market, 2020-2034 (USD Million)
    Figure 2. Integrated Ecosystem
    Figure 3. Research Methodology: Top-Down & Bottom-Up Price
    Figure 4. Market by Geography
    Figure 5. Porter’s Five Forces
    Figure 6. Market by Assay Type
    Figure 7. U.S. C-Reactive Protein Testing Market, by Assay Type, 2024 & 2034 (USD Million)
    Figure 8. Market by Detection Range
    Figure 9. U.S. C-Reactive Protein Testing Market, by Detection Range, 2024 & 2034 (USD Million)
    Figure 10. Market by Disease Area
    Figure 11. U.S. C-Reactive Protein Testing Market, by Disease Area, 2024 & 2034 (USD Million)
    Figure 12. Market by End Use
    Figure 13. U.S. C-Reactive Protein Testing Market, by End Use, 2024 & 2034 (USD Million)